UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Upcoming dementia generics might not succeed’
With the government’s push to enhance the state’s role to fight dementia, l...
by So Jae-hyeon
|
2018-02-27 16:30
라인
Local drugmakers shift focus to convenient drugs
Local drugmakers are diversifying their strategies into developing novel dr...
by So Jae-hyeon
|
2018-02-27 14:26
라인
Eli Lilly Korea earned ₩12 billion from Trulicity sales in 2017
Eli Lilly and Company Korea said Tuesday that its diabetes treatment Trulic...
by Marian Chu
|
2018-02-27 13:52
라인
Bridge Bio to start P1 trial for ulcerative colitis candidate drug
Bridge Biotherapeutics said Tuesday that it plans to start phase 1 clinical...
by Lee Han-soo
|
2018-02-27 11:39
라인
MSD Korea gets larger coverage for Keytruda to treat melanoma
MSD Korea said Tuesday that it got expanded coverage for Keytruda (pembroli...
by Marian Chu
|
2018-02-27 11:33
라인
Han Wha Pharma to sell allergen blocker cream
Han Wha Pharma said recently it would start selling Rhino-Protect PRS, a na...
by So Jae-hyeon
|
2018-02-26 15:46
라인
‘Infusion time for Gaucher patients will be cut to 10 minutes’
Although several therapies for Gaucher disease exist, most take an hour to ...
by Marian Chu
|
2018-02-26 14:55
라인
SK Chemicals to spin off vaccine biz
SK Chemicals said it would spin off its vaccine business, establish it as a...
by So Jae-hyeon
|
2018-02-26 14:34
라인
National Cancer Center, Eutilex aim to develop new CAR-T therapy
A joint research team is developing a new type of chimeric antigen receptor...
by Marian Chu
|
2018-02-26 11:28
라인
Will Koreans without HIV take Truvada braving social, cultural pressure?
Gilead Sciences’ Truvada recently gained an indication to be taken as a PrE...
by Marian Chu
|
2018-02-23 18:41
라인
How will Kolmar raise W1.3 trillion to buy CJ HealthCare?
Kolmar Korea is expected to transform into a pharmaceutical giant with annu...
by So Jae-hyeon
|
2018-02-23 16:21
라인
Metformin warnings to include lactic acidosis death case
Metformin, a first-line treatment for diabetes, will have to add lactic aci...
by Lee Hye-seon
|
2018-02-23 14:43
라인
Merck to build manufacturing-distribution center in Korea
German pharmaceutical company Merck will pour around 53.3 billion won ($49....
by Marian Chu
|
2018-02-23 10:05
라인
Sanofi-Aventis Korea launches diabetes drug Soliqua
Sanofi-Aventis Korea will soon release its diabetes therapy Soliqua in pre-...
by Marian Chu
|
2018-02-23 09:07
라인
Dexid most targeted for generic drug development in 2017
Diabetic polyneuritis treatment Dexid (ingredient: r-thioctic acid trometha...
by Lee Hye-seon
|
2018-02-22 14:55
라인
Merck gets 2 more patents for CRISPR tech
Merck said Tuesday that it got patents in South Korea and Israel for gene e...
by Marian Chu
|
2018-02-22 14:51
라인
Gilead Sciences Korea gets expanded indication for Truvada to prevent HIV
Gilead Sciences Korea said that it got the Ministry of Food and Drug Safety...
by Marian Chu
|
2018-02-21 18:10
라인
Kolmar Korea ups capacity through CJ HealthCare buyout
Kolmar Korea is to become a formidable player in the pharmaceutical industr...
by So Jae-hyeon
|
2018-02-21 15:58
라인
Severance doctors completes spine surgery with O-ARM O2
Severance Hospital said its surgeons successfully finished a spinal surgery...
by Marian Chu
|
2018-02-21 15:26
라인
‘Psoriasis treatment Taltz outperforms rivals’
Lilly Korea’s biological agent Taltz (ingredient: ixekizumab) used as psori...
by Nam Doo-hyun
|
2018-02-21 11:37
-
이전
91
92
93
94
95
96
97
98
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top